tirzepatide weight loss trial vs semaglutide: A new battle in obesity treatment New research from the SURPASS-EARLY

Signs include swelling of the face, lips, tongue, or throat, difficulty breathing, or a rapid heartbeat

Discovery of Highly Potent Tyrosinase Inhibitor, T1, with Significant Anti-Melanogenesis Ability by zebrafish in vivo Assay and Computational Molecular Modeling

Clinical trials have demonstrated that individuals using Wegovy, in conjunction with a reduced-calorie diet and increased physical activity, experienced significant weight loss

Semaglutide Pregnancy Warnings Noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with advanced liver fibrosis: This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus